Metabolites In Pregnant Women Research Articles

Within- and between-day variability and reproducibility of urinary glycol ethers metabolites in pregnant women

Within- and between-day variability and reproducibility of urinary glycol ethers metabolites in pregnant women

The Associations of Urinary DEHP Metabolites in Pregnant Women with Serum Thyroid Hormone and Thyroid-Related Genes in Neonatal Umbilical Cord Blood in Jilin, China

The Associations of Urinary DEHP Metabolites in Pregnant Women with Serum Thyroid Hormone and Thyroid-Related Genes in Neonatal Umbilical Cord Blood in Jilin, China

Prenatal phthalate exposure and sex steroid hormones in newborns: Taiwan Maternal and Infant Cohort Study.

Newborn anogenital distance (AGD) has been associated with prenatal exposure of phthalates. The association between prenatal phthalate exposure and sex steroid hormones in newborns is unclear. This study aimed to examine whether cord-blood sex hormone levels were associated with prenatal phthalate exposure and newborn anogenital distance (AGD). In the Taiwan Maternal and Infant Cohort Study, we recruited 1,676 pregnant women in their third trimester in 2012-2015 in Taiwan. We determined 11 urinary phthalate metabolites in pregnant women, three maternal and five cord-blood steroid sex-hormone concentrations. Five hundred and sixty-five mother-infant pairs with sufficient data were included. Trained neonatologists measured 263 newborns' AGD. We examined the associations of prenatal phthalate metabolite levels with AGD and hormones using linear regression models and evaluated correlations between maternal and cord-blood sex hormone levels and AGD. Compared with the male newborns exposed to maternal phthalate metabolites at the first tertile, AGD was -3.75, -3.43, and -3.53 mm shorter among those exposed at the median tertile of di-2-ethylhexyl phthalate (DEHP) metabolites, monobenzyl phthalate (MBzP), and monomethyl phthalate (MMP), respectively. Compared with those who had exposed at the first tertile, cord-blood follicle-stimulating hormone (FSH) decreased among male newborns exposed at higher levels of MMP, mono-n-butyl phthalate (MnBP), MBzP and DEHP, and among female newborns exposed at higher levels of MMP, MBzP and mono(2-ethyl-5-hydroxyhexyl) phthalate. However, we did not observe significant correlations of maternal or cord-blood sex steroid hormones with newborns' AGDs. Alterations in cord-blood sex steroid hormone levels were associated with prenatal phthalate exposures, particularly in male newborns. Women aspiring to be pregnant should be alerted of the need of reducing phthalate exposure.

Exposure levels and health implications of fungicides, neonicotinoid insecticides, triazine herbicides and their associated metabolites in pregnant women and men

Exposure to pesticides can pose a series of advance effects on human health. However, the exposure levels and health implications of the current use pesticides and their metabolites in both men and pregnant women remain unclear. In this study, an analytical method was developed to quantify fungicides, neonicotinoid insecticides, triazine herbicides, and their metabolites in the human serum. Fifty of the 73 target pesticides and metabolites were detected in the human serum of men and pregnant women from Wuxi, China, which included 11 triazine herbicides and metabolites, 17 neonicotinoid insecticides and metabolites, and 22 fungicides. Fungicides had the highest cumulative concentration (49.5 ng/mL), followed by neonicotinoid insecticides and metabolites (6.38 ng/mL), and triazine herbicides and metabolites (5.10 ng/mL). Moreover, the estimated daily intake (EDI) of fungicides was 10.4 and 12.7 times higher than that of triazine herbicides (included their metabolites) and neonicotinoid insecticides (included their metabolites), respectively. Of the three categories of pesticides, exposure to fungicides contributed to the highest exposure risk within the hazard quotient in the range of 5.1 × 10−3-0.17. Correlation analysis revealed that the pesticide exposure levels in human serum were correlated with their maximum residue levels in vegetables and fruits. Pesticide exposure has also been correlated with the weight and Body Mass Index (BMI) of humans based on structural equation modeling. This study provides new insights into the exposure of men and pregnant women to a cocktail of fungicides, neonicotinoid insecticides, triazine herbicides and their metabolites.

Exposure level of neonicotinoid pesticides and their metabolites in pregnant women in the suburb of Shanghai

In 2021, a total of 151 pregnant women were selected from the suburb of Shanghai. A questionnaire survey was conducted to obtain data about maternal age, gestational week, total annual household income, education level and passive smoking among pregnant women and one spot urine was collected. The concentrations of eight neonicotinoid pesticides and four metabolites in urine were measured by ultra-high performance liquid chromatography-tandem quadrupole time-of-flight mass spectrometry. The differences in detection frequencies and concentrations of neonicotinoid pesticides and their metabolites among pregnant women with different characteristics were compared, and the influencing factors of the detection of neonicotinoid pesticides in urine were analyzed. The results showed that at least one neonicotinoid pesticide was detected in 93.4% (141 samples) of urine samples. The detection frequencies of N-desmethyl-acetamiprid, clothianidin, thiamethoxam, and N-desmethyl-clothianidin were high, about 78.1% (118 samples), 75.5% (114 samples), 68.9% (104 samples), and 44.4% (67 samples), respectively. The median concentration of the sum of all neonicotinoid pesticides was 2.66 μg/g. N-desmethyl-acetamiprid had the highest detection concentration with a median concentration of 1.04 μg/g. A lower urinary detection frequency of imidacloprid and its metabolites was seen in pregnant women aged 30-44 years [OR (95%CI): 0.23 (0.07-0.77)]. A higher detection frequency of clothianidin and its metabolites was seen in pregnant women with per capita annual household income≥100 000 yuan [OR (95%CI): 6.15 (1.56-24.28)]. There was widespread exposure to neonicotinoid pesticides and their metabolites in pregnant women from the suburb of Shanghai, which might pose potential health risks to pregnant women, and maternal age and household income were potential influencing factors of the exposure to neonicotinoid pesticides.

Risk assessment and environmental determinants of urinary phthalate metabolites in pregnant women in Southwest China.

Pregnant women are widely exposed to phthalic acid esters (PAEs) that are commonly used in most aspects of modern life. However, few studies have examined the cumulative exposure of pregnant women to a variety of PAEs derived from the living environmental conditions in China. Therefore, this study aimed to determine the urinary concentrations of nine PAE metabolites in pregnant women, examine the relationship between urinary concentrations and residential characteristics, and conduct a risk assessment analysis. We included 1,888 women who were in their third trimester of pregnancy, and we determined their urinary concentrations of nine PAE metabolites using high-performance gas chromatography-mass spectrometry. The risk assessment of exposure to PAEs was calculated based on the estimated daily intake. A linear regression model was used to analyze the relationship between creatinine-adjusted PAE metabolite concentrations and residential characteristics. The detection rate of five PAE metabolites in the study population was > 90%. Among the PAE metabolites adjusted by creatinine, the urinary metabolite concentration of monobutyl phthalate was found to be the highest. Residential factors, such as housing type, proximity to streets, recent decorations, lack of ventilation in the kitchen, less than equal to three rooms, and the use of coal/kerosene/wood/wheat straw fuels, were all significantly associated with high PAE metabolite concentrations. Due to PAE exposure, ~ 42% (n = 793) of the participants faced potential health risks, particularly attributed to dibutyl phthalate, diisobutyl phthalate, and di(2-ethyl)hexyl phthalate exposure. Living in buildings and using coal/kerosene/wood/wheat straw as domestic fuel can further increase the risks.

Simultaneous quantification of tryptophan metabolites by liquid chromatography tandem mass spectrometry during early human pregnancy.

In this study we describe the development andvalidation of a liquid chromatography mass spectrometry method (LC-MS/MS) to quantify five tryptophan (TRP) metabolites within the kynurenine- and serotonin pathway and apply the method to serum samples of women in the first trimester of pregnancy. A secondary aim was to investigate the correlation between body mass index (BMI) and the five analytes. A LC-MS/MS was developed for the analysis of TRP,kynurenine (KYN), 5-hydroxytryptophan (5-HTP), hydroxytryptamine (5-HT), and 5-hydroxyindole acetic acid (5-HIAA). Serum samples (n=374) were analyzed ofpregnant women (median gestational age: 8±2weeks) participating in a subcohort of the Rotterdam Periconceptional Cohort (Predict study). The LC-MS/MS method provided satisfactory separation of the five analytes (7min run). For all analytes R2 was >0.995. Within- and between-run accuracies were 72-97% and 79-104%, and the precisions were all <15% except for the between-run precisions of the low QC-samples of 5-HTP and 5-HT (both 16%). Analyte concentrations were determined in serum samples of pregnant women (median (IQR)); TRP (µmol/L): 57.5 (13.4), KYN (µmol/L): 1.4 (0.4), 5-HTP (nmol/L): 4.1 (1.2), 5-HT (nmol/L): 615 (323.1), and 5-HIAA (nmol/L): 39.9 (17.0). BMI was negatively correlated with TRP, 5-HTP, and 5-HIAA (TRP: r=-0.18, p<0.001; 5-HTP: r=-0.13, p=0.02; natural log of 5-HIAA: r=-0.11, p=0.04), and positively with KYN (r=0.11, p=0.04). The LC-MS/MS method is able to accurately quantify kynurenine- and serotonin pathway metabolites in pregnant women, providing an opportunity to investigate the role of the TRP metabolism in the (patho)physiology ofpregnancy.

Serum concentrations of phthalate metabolites in pregnant women and their association with gestational diabetes mellitus and blood glucose levels

Phthalate metabolites are widely present in humans and can have many adverse effects on pregnant women. To date, many studies on the effects of phthalate metabolites on the risk of gestational diabetes mellitus (GDM) have been published, but the findings of these studies are controversial. We conducted a case-control study to quantify the concentrations of seven phthalate metabolites in the serum of pregnant women and to investigate their association with the risk of GDM and blood glucose levels in pregnant women. Therefore, 201 serum samples (139 pregnant women with GDM and 62 control serum samples) were collected from Hangzhou, China, between 2011 and 2012. The results showed that mono butyl phthalate (MBP; mean = 4.08 ng/mL) was the most abundant phthalate metabolites in human serum, followed by mono (2-ethylhexyl) phthalate (MEHP; mean = 1.28 ng/mL) and mono isobutyl phthalate (MiBP; mean = 1.20 ng/mL). The other results indicated significant associations between MBP (β = 2.24, 95 % confidence interval (CI): 1.02, 5.07, P = 0.050) and MiBP (β = 1.84, 95 % CI: 1.03, 3.31, P = 0.041) concentrations in human serum and the incidence of GDM. Moreover, serum MBP (β = 0.40, 95 % CI: 0.10, 0.70, P = 0.010) and MiBP levels (β = 0.18, 95 % CI: 0.010, 0.35, P = 0.047) in humans were positively associated with 2-hour blood glucose levels. Our study provides affirmative evidence on previously inconsistent findings that MBP and MiBP exposure may increase the risk of GDM in pregnant women.

Identification of differential metabolites using untargeted metabolomics between gestational diabetes and normal pregnant women.

To study the metabonomics differences between pregnant women with gestational diabetes mellitus (GDM) in the third trimester and those in a group without GDM by screening a group of highly efficient and sensitive markers for GDM and validating previously published early metabolic markers of GDM. A cross-sectional cohort study based on ultra performance liquid chromatography tandem mass spectrometry untargeted metabolomics analysis of serum samples collected from 59 pregnant women with GDM and 59 pregnant women without GDM. A total of 121 metabolites were detected, and 27 were identified as differential metabolites between GDM and control. The combination of 27 metabolic peaks had area under curve (AUC) values of 0.90, 0.92, and 0.93 in the prediction models using support vector machine, partial least squares, and random forest, respectively. Finally, five metabolite biomarkers were selected to construct logistic regression models: L-valine, hypoxanthine, eicosapentaenoic acid, 2-amino-1,3,4-octadecanotriol, and choline. The AUC value of these metabolites was 0.769 between the GDM group and the control group. The discovery of a group of differential metabolites in pregnant women with GDM in the third trimester and in pregnant women without GDM may facilitate the study of the pathologic mechanism of GDM; it may be possible to find an efficient and sensitive alternative GDM detection method.

Urinary phthalate metabolites in pregnant women: occurrences, related factors, and association with maternal hormones.

In this study, we aimed to evaluate phthalate metabolite levels in pregnant women, to explore the factors influencing exposure, and to assess phthalate metabolite levels in relation to thyroid hormone synthesis. We recruited 463 pregnant women and collected urine, blood, and questionnaire data at participant's first prenatal examination. Ten phthalate metabolites were analyzed: mono-isobutyl phthalate (MiBP); mono-methyl phthalate (MMP); mono-ethyl phthalate (MEP); mono-n-butyl phthalate (MnBP); mono-n-octyl phthalate (MOP); mono-benzyl phthalate (MBzP); and the metabolite of di-2-ethylhexyl phthalate (DEHP), which were mono (2-ethylhexyl) phthalate, mono-(2-ethyl-5-oxohexyl) phthalate, and mono-(2-ethyl-5-carboxypentyl) phthalate. Multivariable generalized estimating equation models and linear mixed models were used to predict urinary biomarker concentrations and to assess the associations between phthalate exposure and thyroid hormones. Positive associations were found between phthalate metabolites and lower education (MEP and MOP), living near the road (MEP, MnBP, and ∑DEHP), and consuming more puffed food (MEP and MBzP). In addition, MnBP (percent change [%△] = 4.25; 95% confidence interval [CI] = 0.32, 8.18) and ∑DEHP (%△ = 5.12; 95% CI = 1.25, 8.99) were positively associated with thyroid-stimulating hormones, although MEP and MnBP were inversely associated with free thyroxine and total triiodothyronine. Our findings suggest that certain habits and behaviors were predictive of the positive presence of phthalate metabolites and that certain phthalate esters are associated with altered thyroid hormone levels.

Urinary concentrations and determinants of pyrethroid metabolites in pregnant women from non-rural areas of Yunnan, China.

The study assesses the levels of urinary pyrethroid pesticide (PYR) in women during early pregnancy. The factors associated with exposure are also determined. A total of 480 pregnant women from non-rural areas visiting hospital for prenatal examination during early pregnancy were enrolled. A self-designed, structured questionnaire was used to collect data on potential factors of PYR exposure. Urinary PYR metabolite levels were quantified using high-performance liquid chromatography-tandem mass spectrometry (HPLC-MS/MS). The majority of urine samples (98.8%) contained one or more PYR metabolite, although only a few women self-reported pesticide exposure. Urinary 3-phenoxybenzoic acid (3PBA) levels were close to those reported in certain developed countries. However, the levels of 3-(2,2-dibromovinyl)-2,2-dimethylcyclopropane-1-carboxylic acid (DBCA) and 4-fluoro-3-phenoxybenzoic acid (4F3PBA) were higher than those reported in previous studies. Urinary PYR levels were positively associated with exposure to pesticides, consumption of bananas and oranges, the number of fruit types the women regularly ate, being multiparous, and cooked frequently. They were negatively associated with early pregnancy body mass index (BMI), unemployment, frequent intake of apples, and washing fruits and vegetables with soda or hot water. Pregnant women in non-rural areas were extensively exposed to low levels of PYRs. Dietary intake may be the primary pathway of exposure. The presented findings highlight the importance of using appropriate methods to reduce pesticide residues in food.

Lead exposure and serum metabolite profiles in pregnant women in Mexico City

BackgroundLead (Pb) exposure is a global health hazard causing a wide range of adverse health outcomes. Yet, the mechanisms of Pb toxicology remain incompletely understood, especially during pregnancy. To uncover biological pathways impacted by Pb exposure, this study investigated serum metabolomic profiles during the third trimester of pregnancy that are associated with blood Pb and bone Pb.MethodsWe used data and specimens from 99 women enrolled in the Programming Research in Obesity, Growth, Environment, and Social Stressors birth cohort in Mexico City. Maternal Pb exposure was measured in whole blood samples from the third trimester of pregnancy and in the tibia and patella bones at 1 month postpartum. Third-trimester serum samples underwent metabolomic analysis; metabolites were identified based on matching to an in-house analytical standard library. A metabolome-wide association study was performed using multiple linear regression models. Class- and pathway-based enrichment analyses were also conducted.ResultsThe median (interquartile range) blood Pb concentration was 2.9 (2.6) µg/dL. Median bone Pb, measured in the tibia and patella, were 2.5 (7.3) µg/g and 3.6 (9.5) µg/g, respectively. Of 215 total metabolites identified in serum, 31 were associated with blood Pb (p < 0.05). Class enrichment analysis identified significant overrepresentation of metabolites classified as fatty acids and conjugates, amino acids and peptides, and purines. Tibia and patella Pb were associated with 14 and 8 metabolites, respectively (p < 0.05). Comparing results from bone and blood Pb, glycochenodeoxycholic acid, glycocholic acid, and 1-arachidonoylglycerol were positively associated with blood Pb and tibia Pb, and 7-methylguanine was negatively associated with blood Pb and patella Pb. One metabolite, 5-aminopentanoic acid, was negatively associated with all three Pb measures.ConclusionsThis study identified serum metabolites in pregnant women associated with Pb measured in blood and bone. These findings provide insights on the metabolic profile around Pb exposure in pregnancy and information to guide mechanistic studies of toxicological effects for mothers and children.

Exposure assessment of neonicotinoid insecticides and their metabolites in Chinese women during pregnancy: A longitudinal study

Neonicotinoid insecticides (NNIs) are the most widely used insecticides globally and ubiquitous in the environment, which has led to widespread human exposure. However, studies on internal exposure levels of NNIs and their metabolites in pregnant women are scarce. In this study, we measured nine parent NNIs and ten main metabolites in 1224 urine samples donated by 408 pregnant women at three trimesters. In the urine samples, the unadjusted vs. specific gravity (SG) adjusted median concentrations and detection frequencies (DFs) of desmethyl-acetamiprid (DM-ACE; 1.01 vs. 1.08 ng/mL; DF: 99.7%), 5-hydroxy-imidacloprid (5-hydroxy-IMI; 0.54 vs. 0.56 ng/mL; 98.5%), imidacloprid-olefin (IMI-olefin; 0.41 vs. 0.44 ng/mL; 99.3%), and desnitro-imidacloprid (DN-IMI; 0.12 vs. 0.12 ng/mL; 90.4%) were higher than their corresponding parent NNIs, acetamiprid (ACE; <0.01 vs. <0.01 ng/mL; 26.4%) and imidacloprid (IMI; 0.04 vs. 0.04 ng/mL; 69.9%). The unadjusted and SG-adjusted median concentrations of clothianidin (CLO), thiamethoxam (THM), and desmethyl-clothianidin (DM-CLO) were 0.05 vs. 0.07, 0.05 vs. 0.06, and 0.04 vs. 0.05 ng/mL, with the DFs of 61.0%, 57.5%, and 75.7%, respectively. The cumulative exposure level, imidacloprid-equivalent total NNIs (IMIeq), was generated by the relative potency factor approach considering the toxic effects of NNIs and their metabolites. The unadjusted IMIeq varied from 0.17 ng/mL (SG-adjusted: 0.20) to 1969 ng/mL (SG-adjusted: 1817) with a median of 14.1 ng/mL (SG-adjusted: 14.1). A decreased trend was observed in urinary NNIs and their metabolites throughout the three trimesters. Maternal age, educational level, and household income were related to the concentrations of NNIs and their metabolites. DM-ACE, 5-hydroxy-IMI, and IMI-olefin were significantly lower in winter than in autumn; DN-IMI, THM, CLO, and DM-CLO were significantly higher in both summer and autumn than in winter. The maximum estimated daily intake of IMIeq [34.8 μg/kg-body weight (bw)/d] was lower than the chronic reference dose of IMI (57 μg/kg-bw/d) currently recommended by the United States Environmental Protection Agency. Human health risk of exposure to NNIs and their main metabolites warranted further studies.

Urinary levels of PAH metabolites in pregnant women and their correlation with sociodemographic factors and PM2.5 exposure in an urban and a suburban area

Exposure to PAHs during pregnancy is associated with adverse birth outcomes. The objectives of this study were to determine the urinary levels of PAH metabolites in pregnant women and to evaluate their association with sociodemographic and lifestyle variables and exposure to atmospheric PM2.5. Subjects of 80 non-smoking pregnant women from three regions in an urban area (Isfahan city) and one region of suburb area (Mobarakeh town) were recruited to the study. The urine samples of women were collected during their first (spring) and third (autumn) trimester of pregnancy. Urinary PAHs’ metabolites including 1-naphthol (1-NAP), 2-naphthol (2-NAP), 9-phenanthrol (9-PHN), and 1-hydroxypyrene (1-OHP) were analysed by a GC/MS after their extraction and derivatization. Ambient PM2.5 data for the study period were collected from air pollution monitoring stations. The mean urinary concentrations of 1-NAP, 2-NAP, 9-PHN and 1-HOP in spring were 3.3, 2.2, 0.9 and 8.8 μg g−1 creatinine, and those in autumn accounted for 5.2, 3.0, 11.2 and 11.3 μg g−1 creatinine, respectively. Coincidently, the mean atmospheric PM2.5 concentrations of 23.2 μg m−3 in spring and 37.3 μg m−3 in autumn were attained. The concentration of the metabolites in the urban area was higher than that in the suburban area in both seasons which was following the ambient levels of PM2.5. A significant positive correlation between the metabolites and ambient PM2.5 was observed (p value < 0.05). Although the socio-demographic factors affected the level of exposure, the difference was not statistically significant (p value < 0.05). Residents of the urban area were exposed to a higher level of PAHs due to air pollution especially in the cold season.

Urinary concentrations of phthalate metabolites in pregnant women living near Chapala Lake, Jalisco, Mexico

Phthalates are esters of phthalic acid used in a broad array of consumer products and food contact surfaces. Phthalates are known endocrine disruptors and oxidant stressors, and exposure has been associated with premature birth, asthma, obesity, insulin resistance and endometriosis. Though many industrializing countries are known to manufacture phthalates, few studies have examined exposure to phthalates in this context, let alone in rural communities where phthalate-containing products are widely used. We evaluated the presence of 16 phthalate metabolites in third trimester pregnant women in three rural communities near the largest lake in Mexico, Lake Chapala, by liquid chromatography coupled to tandem mass spectrometry in 90 urine samples. Phthalate metabolites were found in all samples, where the highest concentration was 1830 ng/mL in mono-ethyl phthalate (mEP), and it was present in 98.9% of all samples. These findings suggest the need for further research on the effect of endocrine disrupting chemicals in developing countries, and public health guidance on opportunities for prevention.

Early life exposure to organophosphate pesticides, behavioral outcomes, and adaptive skills in adolescents from the CHAMACOS study

Background: Epidemiologic studies have linked early life exposure to organophosphate (OP) pesticides with poorer cognitive and behavioral development in school age children. However, few studies have examined whether these associations persist into adolescence.Methods: We investigated associations of early life OP pesticide exposure, assessed by measurement of urinary dialkyl phosphate (DAP) metabolites in pregnant women (samples collected at 13 and 26 weeks’ gestation) and their children (repeated samples collected from birth to 5 years), with maternal-reported behaviors assessed longitudinally at ages 14, 16, and 18 years using the Behavior Assessment System for Children, 2nd edition (BASC-2) in 335 adolescents participating in the Center for the Health Assessment of Mothers and Children of Salinas (CHAMACOS) study. We used generalized estimating equation models to assess longitudinal effects and examined differences by sex.Results: Median (IQR) prenatal dimethyl phosphate (DM), diethyl phosphate (DE), and total DAP concentrations were 97.8 (47.0-233.5), 23.9 (11.2-44.4), and 128.2 (72.3-290.1) nmol/g creatinine. We observed that higher prenatal creatinine-adjusted DAP concentrations were associated with more maternal-reported hyperactivity (β per 10-fold increase = 2.0; 95% CI: 0.3, 3.7), aggression (β = 1.5; 95% CI: 0.1, 2.8), and withdrawal (β = 2.6; 95% CI: 0.6, 4.5), and with poorer adaptability (β = -2.4; 95% CI: -4.5, -0.2), activities of daily living (β = -3.3; 95% CI: -5.6, -1.1), and functional communication (β = -3.3; 95% CI: -5.3, -1.3). Associations were similar for prenatal DMs and generally stronger in boys than in girls. We observed null associations for prenatal DE concentrations and childhood OP pesticide metabolites.Conclusion: Our findings indicate that prenatal, but not childhood, OP pesticide exposure may be associated with behavioral problems and adaptive deficits that persist into adolescence. Public health interventions and public policy changes to protect developing brains from avoidable environmental insults, such as OP pesticides, are warranted.

Arsenic exposure and urinary metabolites during pregnancy and its association with birth outcomes in Tacna, Peru

Background: The province of Tacna, Peru, presents arsenic levels in drinking water above the WHO suggested limit of 10µg/L. One of the adverse effects during pregnancy is the increased rate of small for gestational age (SGA). However, comparing to the rest of Peru, SGA in Tacna is lower but large for gestational age (LGA) is the highest in all the country. Here we have evaluated the water and urinary arsenic metabolites in pregnant women and their association with birth outcomes.Methods: We estimated the arsenic concentration in drinking water and urine during the second and third trimester of pregnancy in 150 women that live in Tacna from February to July,2019. Water arsenic was evaluated qualitatively, and urinary arsenic (tAs, AsIII, AsV, MMA and DMA) was quantified by HPLC-MS. Primary ((MMA+DMA)/tAs) and Secondary (DMA/(MMA+DMA)) methylation-indexes (PMI/SMI) were generated. Reproductive outcomes were assessed as tertiles of exposure. Results: We found an almost even distribution of arsenic exposure in drinking water (30.43% to ≤10µg/L; and 34.78% for 25µg/L and 34.78% for ≥50µg/L). Mean total urinary arsenic was higher according to the exposure group (38.08, 51.86 and 65.38ng/mL, respectively). It is appreciated an increase of SGA proportion by tertile of total urinary arsenic (tAs) (2.38%, 7.32% and 8.57%) although not significantly. On the other hand, the proportion of LGA is reduced when increasing the tertile of %AsV: 38.1%, 35,8% and 28.57%, respectively. Conclusions: Although no significant relationship was found between arsenic exposure and births outcomes, there is a tendency of higher risk of SGA with increasing tertile of tAs. On the other, according to recent research, the aymara ethnic population, Tacna’s main ethnicity, is characterized by high birthweights for gestational age, and our results show that higher %AsV might shift this normal pattern, reducing the proportion of LGA; nonetheless, greater sample size is required.

Biomonitoring of emerging DINCH metabolites in pregnant women in charleston, SC: 2011–2014

Due to the mounting evidence that phthalates, specifically di-2-ethylhexyl phthalate and dibutyl phthalate, produce adverse endocrine effects in humans and wildlife, the use of other chemicals as replacements has increased. One of the most commonly encountered phthalate replacements is di(isononyl)cyclohexane-1,2-dicarboxylate (DINCH). Currently, little is known about the prevalence of human exposure, bioactivity, and endocrine disrupting potential of DINCH. We sampled urine from 100 pregnant women during the second trimester of pregnancy living in Charleston, SC between 2011 and 2014 and measured the following DINCH metabolites by LC-MS/MS: cyclohexane-1,2-dicarboxylic acid-mono(hydroxy-isononyl) ester (OH-MINCH), cyclohexane-1,2-dicarboxylic acid-mono(oxo-isononyl) ester (oxo-MINCH), and cyclohexane-1,2-dicarboxylic acid-monocarboxy isooctyl ester (cx-MINCH). These metabolites were also tested on human estrogen receptor alpha and progesterone receptor beta transactivation assays in vitro. OH-MINCH was detected in 98% of urine samples. The specific gravity-adjusted median (interquartile range) OH-MINCH concentration was 0.20 (0.25) ng/mL, and concentrations were significantly higher in African American women compared to Caucasian women (p = 0.01). DINCH metabolite concentrations were consistent between years, and they did not exhibit estrogenic or progestogenic activity in vitro. Human exposure to these emerging compounds should continue to be monitored, especially in vulnerable populations, to ensure the replacement of phthalates by DINCH is not a case of regrettable substitution.

The association of Vitamin D levels with lipid metabolism during pregnancy

Vitamin D deficiency is common in pregnant women, and it is associated with multiple gestational complications, fetal intrauterine dysplasia, and maternal and infant health in postpartum period. Vitamin D involved in lipid metabolism may affect maternal-fetal health during pregnancy through this biological pathway. This review provides an overview of three main aspects, including, the effect of vitamin D on the mechanism of lipid metabolism, the relationship between vitamin D and lipid metabolites in pregnant women and women with pregnancy complications. An association between vitamin D status and lipid metabolism at different stages of pregnancy has been justified in most current studies, and the underlying mechanism has also been partly elucidated. Given some gestational complications, such as gestational diabetes and pre-eclampsia, pregnant women with these conditions are often associated with abnormal lipid metabolism and vitamin D deficiency. There is no doubt that the studies on the vitamin D supplementation and lipid metabolism improvement could have crucial clinical significance for this population. More randomized controlled trials with multi-center, large sample and multi-dose interventions are needed in the future to provide scientific evidence for clinical practice.

Changes in tryptophan metabolism during pregnancy and postpartum periods: Potential involvement in postpartum depressive symptoms

BackgroundMany women experience depressive symptoms during pregnancy and postpartum periods. These depressive symptoms are often accompanied by other inflammatory morbidities present during pregnancy. Tryptophan (TRP) metabolism has attracted considerable attention due to its influence on the onset of depression via induction of inflammation. We examined the changes in plasma levels of TRP metabolites in pregnant women with depressive symptoms during pregnancy and/or the postpartum period. MethodsIn line with a previous analysis using the Edinburgh Postnatal Depression Scale (EPDS), participants were divided into a non-depressive (ND) group, a postpartum depressive (PD) group, a temporary gestational depressive (TG) group, and a continuous depressive (CD) group. Blood samples were collected before and 1 month after delivery. The concentrations of plasma TRP metabolites were measured using high-performance liquid chromatography (HPLC). ResultsThere are differences in plasma levels of TRP metabolites during pregnancy and postpartum periods between the ND group and the PD group, but not the TG or CD group. In the PD group, plasma levels of kynurenine (KYN) and kynurenic acid (KA), and KYN/TRP and KA/KYN ratio during the pregnancy period were higher and 3-hydroxyanthranilic acid (3HAA) during the postpartum period was lower than those in the ND group. LimitationsHistories regarding mood disorders before pregnancy were not assessed. ConclusionsThe higher plasma levels of KYN and KA, and KYN/TRP and KA/KYN ratio during pregnancy period and lower plasma level of 3HAA during the postpartum period could be useful predictive and diagnostic markers of postpartum depressive symptoms.